Clinical factors associated with fatigue over time in paediatric oncology patients receiving chemotherapy

Chao Hsing Yeh, Y. C. Chiang, L. Lin, C. P. Yang, L. C. Chien, M. A. Weaver, H. L. Chuang

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to investigate the relationships between clinical factors (including haemoglobin value, chemotherapeutic agents, and corticosteroid use) and changing patterns of fatigue before and for the next 10 days following the start of a new round of chemotherapy in children with cancer. A prospective longitudinal design was used to collect data from 48 paediatric oncology patients who were about to begin a new round of chemotherapy and their parents. Fatigue levels were assessed using multidomain questionnaires with three categories of patient self-report (including 'General Fatigue', 'Sleep/Rest Fatigue', and 'Cognitive Fatigue') and four categories of parent proxy-report (including 'Lack of Energy', 'Unable to Function', 'Altered Sleep', and 'Altered Mood'). The findings suggest that fatigue from both patient self-report and parent proxy-report changed significantly over time. The major findings from this study are that patients have more problems with fatigue in the first few days after the start of a cycle of chemotherapy. Corticosteroid use and haemoglobin value were associated with significant increases in fatigue that were sustained for several days and reached the highest level of fatigue at day 5 for those receiving concurrent steroids. The association of chemotherapeutic agents with fatigue varied between patient self-report and parent report, but the type of chemotherapeutic agents used was not associated with most changes in fatigue.

Original languageEnglish (US)
Pages (from-to)23-29
Number of pages7
JournalBritish Journal of Cancer
Volume99
Issue number1
DOIs
StatePublished - Jul 8 2008
Externally publishedYes

Fingerprint

Fatigue
Pediatrics
Drug Therapy
Self Report
Proxy
Adrenal Cortex Hormones
Sleep
Hemoglobins
Parents
Steroids

Keywords

  • Chemotherapy
  • Clinical factors
  • Corticosteroids
  • Fatigue
  • Paediatric oncology patient

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Clinical factors associated with fatigue over time in paediatric oncology patients receiving chemotherapy. / Yeh, Chao Hsing; Chiang, Y. C.; Lin, L.; Yang, C. P.; Chien, L. C.; Weaver, M. A.; Chuang, H. L.

In: British Journal of Cancer, Vol. 99, No. 1, 08.07.2008, p. 23-29.

Research output: Contribution to journalArticle

Yeh, Chao Hsing ; Chiang, Y. C. ; Lin, L. ; Yang, C. P. ; Chien, L. C. ; Weaver, M. A. ; Chuang, H. L. / Clinical factors associated with fatigue over time in paediatric oncology patients receiving chemotherapy. In: British Journal of Cancer. 2008 ; Vol. 99, No. 1. pp. 23-29.
@article{90950b18bf324af0bac0608c61a16790,
title = "Clinical factors associated with fatigue over time in paediatric oncology patients receiving chemotherapy",
abstract = "The purpose of this study was to investigate the relationships between clinical factors (including haemoglobin value, chemotherapeutic agents, and corticosteroid use) and changing patterns of fatigue before and for the next 10 days following the start of a new round of chemotherapy in children with cancer. A prospective longitudinal design was used to collect data from 48 paediatric oncology patients who were about to begin a new round of chemotherapy and their parents. Fatigue levels were assessed using multidomain questionnaires with three categories of patient self-report (including 'General Fatigue', 'Sleep/Rest Fatigue', and 'Cognitive Fatigue') and four categories of parent proxy-report (including 'Lack of Energy', 'Unable to Function', 'Altered Sleep', and 'Altered Mood'). The findings suggest that fatigue from both patient self-report and parent proxy-report changed significantly over time. The major findings from this study are that patients have more problems with fatigue in the first few days after the start of a cycle of chemotherapy. Corticosteroid use and haemoglobin value were associated with significant increases in fatigue that were sustained for several days and reached the highest level of fatigue at day 5 for those receiving concurrent steroids. The association of chemotherapeutic agents with fatigue varied between patient self-report and parent report, but the type of chemotherapeutic agents used was not associated with most changes in fatigue.",
keywords = "Chemotherapy, Clinical factors, Corticosteroids, Fatigue, Paediatric oncology patient",
author = "Yeh, {Chao Hsing} and Chiang, {Y. C.} and L. Lin and Yang, {C. P.} and Chien, {L. C.} and Weaver, {M. A.} and Chuang, {H. L.}",
year = "2008",
month = "7",
day = "8",
doi = "10.1038/sj.bjc.6604434",
language = "English (US)",
volume = "99",
pages = "23--29",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Clinical factors associated with fatigue over time in paediatric oncology patients receiving chemotherapy

AU - Yeh, Chao Hsing

AU - Chiang, Y. C.

AU - Lin, L.

AU - Yang, C. P.

AU - Chien, L. C.

AU - Weaver, M. A.

AU - Chuang, H. L.

PY - 2008/7/8

Y1 - 2008/7/8

N2 - The purpose of this study was to investigate the relationships between clinical factors (including haemoglobin value, chemotherapeutic agents, and corticosteroid use) and changing patterns of fatigue before and for the next 10 days following the start of a new round of chemotherapy in children with cancer. A prospective longitudinal design was used to collect data from 48 paediatric oncology patients who were about to begin a new round of chemotherapy and their parents. Fatigue levels were assessed using multidomain questionnaires with three categories of patient self-report (including 'General Fatigue', 'Sleep/Rest Fatigue', and 'Cognitive Fatigue') and four categories of parent proxy-report (including 'Lack of Energy', 'Unable to Function', 'Altered Sleep', and 'Altered Mood'). The findings suggest that fatigue from both patient self-report and parent proxy-report changed significantly over time. The major findings from this study are that patients have more problems with fatigue in the first few days after the start of a cycle of chemotherapy. Corticosteroid use and haemoglobin value were associated with significant increases in fatigue that were sustained for several days and reached the highest level of fatigue at day 5 for those receiving concurrent steroids. The association of chemotherapeutic agents with fatigue varied between patient self-report and parent report, but the type of chemotherapeutic agents used was not associated with most changes in fatigue.

AB - The purpose of this study was to investigate the relationships between clinical factors (including haemoglobin value, chemotherapeutic agents, and corticosteroid use) and changing patterns of fatigue before and for the next 10 days following the start of a new round of chemotherapy in children with cancer. A prospective longitudinal design was used to collect data from 48 paediatric oncology patients who were about to begin a new round of chemotherapy and their parents. Fatigue levels were assessed using multidomain questionnaires with three categories of patient self-report (including 'General Fatigue', 'Sleep/Rest Fatigue', and 'Cognitive Fatigue') and four categories of parent proxy-report (including 'Lack of Energy', 'Unable to Function', 'Altered Sleep', and 'Altered Mood'). The findings suggest that fatigue from both patient self-report and parent proxy-report changed significantly over time. The major findings from this study are that patients have more problems with fatigue in the first few days after the start of a cycle of chemotherapy. Corticosteroid use and haemoglobin value were associated with significant increases in fatigue that were sustained for several days and reached the highest level of fatigue at day 5 for those receiving concurrent steroids. The association of chemotherapeutic agents with fatigue varied between patient self-report and parent report, but the type of chemotherapeutic agents used was not associated with most changes in fatigue.

KW - Chemotherapy

KW - Clinical factors

KW - Corticosteroids

KW - Fatigue

KW - Paediatric oncology patient

UR - http://www.scopus.com/inward/record.url?scp=46349092799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46349092799&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6604434

DO - 10.1038/sj.bjc.6604434

M3 - Article

C2 - 18577992

AN - SCOPUS:46349092799

VL - 99

SP - 23

EP - 29

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 1

ER -